Compare Enphase Energy Inc (ENPH) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Medpace Holdings Inc — how do they compare? Enphase Energy Inc trades at $32.7 (market cap $4.35B), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 3.9× Enphase Energy Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Medpace Holdings Inc for 14 Days on average.
| ENPH | MEDP | |
|---|---|---|
Market Cap | $4.35B | $16.82B |
Volume | 5,068,595 | 223,093 |
Sector | Energy | Health |
52-Week High | $72.33 | $630.19 |
52-Week Low | $26.12 | $393.42 |
Typical Hold Time | 72 Days | 14 Days |
Enterprise Value | $3.99B | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.81, down 2.06% on the day, with a bearish technical signal from moving averages and mixed recent earnings. The company reported revenue of $1.47B and net income of $172.13M for 2025, with a P/E ratio of 32.58. Recent news highlights product approvals and manufacturing milestones for AI data center power solutions, though the solar sector faces headwinds from high borrowing costs.
The outlook is cautious; while analyst consensus is a Buy with a $42.90 price target, near-term risks include sector volatility and recent earnings misses. Long-term opportunities hinge on execution in the energy technology and AI infrastructure markets, but investors should weigh competitive pressures and macroeconomic factors affecting solar project financing.
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
